Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 67,059	$ 89,425
Medicare shared savings revenue	$ 767,744
Revenue to recover costs incurred percentage	100.00%
Product return allowance	$ 24,264	26,839
FDIC insurance amount	250,000
Insured excess	$ 3,087,985	18,227
Percentage of customers accounts receivable billings	48.10%
Accounts receivable net	$ 233,107	165,464
Net patient services accounts receivable	112,125	71,655
Allowance of doubtful accounts	13,972	13,972
Accounts receivable bill amount	$ 13,180	$ 15,498
Concentration risk, percentage	10.00%
Stock Options [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	3,066,750	3,111,750
Product revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 12,690	$ 5,782
Minimum [Member]
Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	5 years
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	7 years
Warrant [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	59,742,034	51,352,986
Unissued [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	200,000	200,000
Common Stock Issuable [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	13,750,000	13,750,000
BTG patient service revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 54,369	$ 35,779
Consulting revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities		$ 47,864
Convertible Notes Payable [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)		10,298,333